1604 related articles for article (PubMed ID: 25823768)
1. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
2. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
[TBL] [Abstract][Full Text] [Related]
4. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
[TBL] [Abstract][Full Text] [Related]
6. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
[TBL] [Abstract][Full Text] [Related]
7. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
Trad KS; Turgeon DG; Deljkich E
Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
[TBL] [Abstract][Full Text] [Related]
9. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
Testoni PA; Vailati C; Testoni S; Corsetti M
Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.
Håkansson B; Montgomery M; Cadiere GB; Rajan A; Bruley des Varannes S; Lerhun M; Coron E; Tack J; Bischops R; Thorell A; Arnelo U; Lundell L
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1261-70. PubMed ID: 26463242
[TBL] [Abstract][Full Text] [Related]
11. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
Huang X; Chen S; Zhao H; Zeng X; Lian J; Tseng Y; Chen J
Surg Endosc; 2017 Mar; 31(3):1032-1044. PubMed ID: 27495332
[TBL] [Abstract][Full Text] [Related]
13. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
[TBL] [Abstract][Full Text] [Related]
14. Transoral Incisionless Fundoplication (TIF 2.0): A Meta-Analysis of Three Randomized, Controlled Clinical Trials.
Gerson L; Stouch B; Lobonţiu A
Chirurgia (Bucur); 2018; 113(2):173-184. PubMed ID: 29733015
[TBL] [Abstract][Full Text] [Related]
15. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
McCarty TR; Itidiare M; Njei B; Rustagi T
Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
[TBL] [Abstract][Full Text] [Related]
17. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
[TBL] [Abstract][Full Text] [Related]
18. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
[TBL] [Abstract][Full Text] [Related]
19. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
